spacer
spacer

PDBsum entry 1rt4

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Nucleotidyltransferase PDB id
1rt4

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
537 a.a. *
404 a.a. *
Ligands
PO4
UC1
Waters ×3
* Residue conservation analysis
PDB id:
1rt4
Name: Nucleotidyltransferase
Title: HIV-1 reverse transcriptase complexed with uc781
Structure: HIV-1 reverse transcriptase. Chain: a. Engineered: yes. HIV-1 reverse transcriptase. Chain: b. Engineered: yes
Source: HIV-1 m:b_hxb2r. Organism_taxid: 11706. Strain: hxb2 isolate. Gene: pol. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
Biol. unit: Dimer (from PQS)
Resolution:
2.90Å     R-factor:   0.237     R-free:   0.295
Authors: J.Ren,D.K.Stammers,D.I.Stuart
Key ref:
J.Ren et al. (1998). Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives. Biochemistry, 37, 14394-14403. PubMed id: 9772165 DOI: 10.1021/bi981309m
Date:
29-Jul-98     Release date:   29-Jul-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
537 a.a.*
Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
404 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chains A, B: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
Bound ligand (Het Group name = PO4)
matches with 55.56% similarity
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: Chains A, B: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: Chains A, B: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: Chains A, B: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: Chains A, B: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/bi981309m Biochemistry 37:14394-14403 (1998)
PubMed id: 9772165  
 
 
Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives.
J.Ren, R.M.Esnouf, A.L.Hopkins, J.Warren, J.Balzarini, D.I.Stuart, D.K.Stammers.
 
  ABSTRACT  
 
The carboxanilides are nonnucleoside inhibitors (NNIs) of HIV-1 reverse transcriptase (RT), of potential clinical importance. The compounds differ in potency and in their retention of potency in the face of drug resistance mutations. Whereas UC-84, the prototype compound, only weakly inhibits many RTs bearing single point resistance mutations, inhibition by UC-781 is little affected. It has been proposed that UC-38 and UC-781 may form quaternary complexes with RT at a site other than the known binding pocket of other NNIs. X-ray crystal structures of four HIV-1 RT-carboxanilide complexes (UC-10, UC-38, UC-84, and UC-781) reported here reveal that all four inhibitors bind in the usual NNI site, forming binary 1:1 complexes with RT in the absence of substrates with the amide/thioamide bond in cis conformations. For all four complexes the anilide rings of the inhibitors overlap aromatic rings of many other NNIs bound to RT. In contrast, the second rings of UC-10, UC-84, and UC-781 do not bind in equivalent positions to those of other "two-ring" NNIs such as alpha-APA or HEPT derivatives. The binding modes most closely resemble that of the structurally dissimilar NNI, Cl-TIBO, with a common hydrogen bond between each carboxanilide NH- group and the main-chain carbonyl oxygen of Lys101. The binding modes differ slightly between the UC-10/UC-781 and UC-38/UC-84 pairs of compounds, apparently related to the shorter isopropylmethanoyl substituents of the anilide rings of UC-38/UC-84, which draws these rings closer to residues Tyr181 and Tyr188. This in turn explains the differences in the effect of mutated residues on the binding of these compounds.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19374380 S.E.Nichols, R.A.Domaoal, V.V.Thakur, J.Tirado-Rives, K.S.Anderson, and W.L.Jorgensen (2009).
Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures.
  J Chem Inf Model, 49, 1272-1279.  
17949071 G.Barreiro, C.R.Guimarães, I.Tubert-Brohman, T.M.Lyons, J.Tirado-Rives, and W.L.Jorgensen (2007).
Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.
  J Chem Inf Model, 47, 2416-2428.  
17918923 G.Barreiro, J.T.Kim, C.R.Guimarães, C.M.Bailey, R.A.Domaoal, L.Wang, K.S.Anderson, and W.L.Jorgensen (2007).
From docking false-positive to active anti-HIV agent.
  J Med Chem, 50, 5324-5329.  
17477343 J.L.Medina-Franco, K.Martínez-Mayorga, C.Juárez-Gordiano, and R.Castillo (2007).
Pyridin-2(1H)-ones: A Promising Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
  ChemMedChem, 2, 1141-1147.  
21132092 W.L.Jorgensen, K.P.Jensen, and A.N.Alexandrova (2007).
Polarization Effects for Hydrogen-Bonded Complexes of Substituted Phenols with Water and Chloride Ion.
  J Chem Theory Comput, 3, 1987-1992.  
16911530 J.Ren, C.E.Nichols, A.Stamp, P.P.Chamberlain, R.Ferris, K.L.Weaver, S.A.Short, and D.K.Stammers (2006).
Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
  FEBS J, 273, 3850-3860.
PDB codes: 2hnd 2hny 2hnz
16508186 T.Maruyama, S.Kozai, Y.Demizu, M.Witvrouw, C.Pannecouque, J.Balzarini, R.Snoecks, G.Andrei, and E.De Clercq (2006).
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives.
  Chem Pharm Bull (Tokyo), 54, 325-333.  
16163450 J.L.Medina-Franco, A.Golbraikh, S.Oloff, R.Castillo, and A.Tropsha (2005).
Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
  J Comput Aided Mol Des, 19, 229-242.  
15016861 E.N.Peletskaya, A.A.Kogon, S.Tuske, E.Arnold, and S.H.Hughes (2004).
Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
  J Virol, 78, 3387-3397.
PDB code: 1r0a
14748000 F.Daeyaert, M.de Jonge, J.Heeres, L.Koymans, P.Lewi, M.H.Vinkers, and P.A.Janssen (2004).
A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets.
  Proteins, 54, 526-533.  
15249669 J.D.Pata, W.G.Stirtan, S.W.Goldstein, and T.A.Steitz (2004).
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.
  Proc Natl Acad Sci U S A, 101, 10548-10553.
PDB code: 1tv6
15544453 N.Sluis-Cremer, N.A.Temiz, and I.Bahar (2004).
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
  Curr HIV Res, 2, 323-332.  
12369088 E.De Clercq (2002).
New anti-HIV agents and targets.
  Med Res Rev, 22, 531-565.  
12208978 P.P.Chamberlain, J.Ren, C.E.Nichols, L.Douglas, J.Lennerstrand, B.A.Larder, D.I.Stuart, and D.K.Stammers (2002).
Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
  J Virol, 76, 10015-10019.
PDB codes: 1lw0 1lw2 1lwc 1lwe 1lwf
10891872 E.De Clercq (2000).
Novel compounds in preclinical/early clinical development for the treatment of HIV infections.
  Rev Med Virol, 10, 255-277.  
10976576 H.G.Hahn, H.K.Rhee, C.K.Lee, and K.J.Whang (2000).
Designs and syntheses of oxathiin carboxanilide analogues and their antiviral activities.
  Arch Pharm Res, 23, 315-323.  
10799511 J.Ren, C.Nichols, L.E.Bird, T.Fujiwara, H.Sugimoto, D.I.Stuart, and D.K.Stammers (2000).
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding.
  J Biol Chem, 275, 14316-14320.
PDB code: 1ep4
10681546 J.Ren, J.Diprose, J.Warren, R.M.Esnouf, L.E.Bird, S.Ikemizu, M.Slater, J.Milton, J.Balzarini, D.I.Stuart, and D.K.Stammers (2000).
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
  J Biol Chem, 275, 5633-5639.
PDB codes: 1dtq 1dtt
11080630 J.Ren, J.Milton, K.L.Weaver, S.A.Short, D.I.Stuart, and D.K.Stammers (2000).
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase.
  Structure, 8, 1089-1094.
PDB codes: 1fk9 1fko 1fkp
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer